Korro Bio, Inc. (KRRO) — Financial Flexibility Index
Korro Bio, Inc. (KRRO) has a Financial Flexibility Index of -0.25x as of March 2026. Free cash flow of $-16.05 Million (operating CF $-16.07 Million minus capex $21.00K) represents 0% of total liabilities ($63.99 Million). Check Korro Bio, Inc. (KRRO) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Korro Bio, Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Korro Bio, Inc. across 9 annual periods. See KRRO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Korro Bio, Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Korro Bio, Inc.. For the full company profile including market capitalisation, see KRRO company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.26x | $-78.04 Million | $-78.56 Million | $62.07 Million | ▼ -96.3% |
| 2024 | -0.64x | $-42.17 Million | $-60.07 Million | $65.83 Million | ▲ +44.2% |
| 2023 | -1.15x | $-59.45 Million | $-67.28 Million | $51.75 Million | ▼ -309.8% |
| 2022 | -0.28x | $-48.43 Million | $-53.65 Million | $172.77 Million | ▲ +44.7% |
| 2021 | -0.51x | $-27.65 Million | $-32.09 Million | $54.53 Million | ▲ +4.9% |
| 2020 | -0.53x | $-38.52 Million | $-45.19 Million | $72.23 Million | ▼ -184.4% |
| 2019 | 0.63x | $35.28 Million | $34.22 Million | $55.86 Million | ▲ +439.1% |
| 2018 | -0.19x | $-16.59 Million | $-17.02 Million | $89.06 Million | ▲ +27.8% |
| 2017 | -0.26x | $-12.75 Million | $-14.61 Million | $49.43 Million | — |